Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Wei Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization/School of Medical, Shihezi University, Shihezi, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Surface Plasmon Resonance, Gallic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Independently Funded to Support Scientific Research Projects of Shihezi University, Major Science and Technology Projects of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
The traditional formulation Hanchuan zupa granules (HCZPs) have been widely used for controlling coronavirus disease 2019 (COVID‐19). However, its active components remain unknown. Here, HCZP components targeting the spike receptor‐binding domain (S‐RBD) of SARS‐CoV‐2 were investigated using a surface plasmon resonance (SPR) biosensor‐based active ingredient recognition system (SPR‐AIRS). Recombinant S‐RBD proteins were immobilized on the SPR chip by amine coupling for the prescreening of nine HCZP medicinal herbs. Ultra‐performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) identified gallic acid (GA) and methyl gallate (MG) from Rosa rugosa as S‐RBD ligands, with K D values of 2.69 and 0.95 μM, respectively, as shown by SPR. Molecular dynamics indicated that GA formed hydrogen bonds with G496, N501, and Y505 of S‐RBD, and MG with G496 and Y505, inhibiting S‐RBD binding to angiotensin‐converting enzyme 2 (ACE2). SPR‐based competition analysis verified that both compounds blocked S‐RBD and ACE2 binding, and SPR demonstrated that GA and MG bound to ACE2 ( K D = 5.10 and 4.05 μM, respectively), suggesting that they blocked the receptor and neutralized SARS‐CoV‐2. Infection with SARS‐CoV‐2 pseudovirus showed that GA and MG suppressed viral entry into 293T‐ACE2 cells. These S‐RBD inhibitors have potential for drug design, while the findings provide a reference on HCZP composition and its use for treating COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization/School of Medical, Shihezi University, Shihezi, China.
- State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
- Corps Center for Food and Drug Evaluation and Verification, Xinjiang Production and Construction Corps Market Supervision Administration, Urumqi, China.
Förderung
- National Natural Science Foundation of China
- Independently Funded to Support Scientific Research Projects of Shihezi University
- Major Science and Technology Projects of Xinjiang Uygur Autonomous Region
- Fundamental Research Funds for the Central Universities
- Open Funds for the State Key Laboratory of Natural and Biomimetic Drugs
- Youth Innovation Training Talent Plan of Shihezi University
- Shihezi University
Zitieren
APA
Yu, W., Yi, S. Z., Jiang, C. Y., Guan, J. W., Xue, R., Zhang, X. X., Zeng, T., Tang, H., Chen, W., & Han, B. (2024). Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose. Biomedical Chromatography. https://doi.org/10.1002/bmc.5987
Vancouver
Yu W, Yi SZ, Jiang CY, Guan JW, Xue R, Zhang XX, et al. Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose. Biomedical Chromatography. 2024. doi:10.1002/bmc.5987
BibTeX
@article{Yu2024,
author = {Yu, Wei and Yi, Sheng-Zhe and Jiang, Cheng-Yu and Guan, Jia-Wei and Xue, Rui and Zhang, Xu-Xuan and Zeng, Tao and Tang, Hui and Chen, Wen and Han, Bo},
title = {Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5987}
}
EUVIMED